Position in VIR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,563,756
-$481,491 QoQ
Shares Held
2,071,848
-34.4% QoQ
Ownership
1.23%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,690,752,415 across 354 Biotechnology names. VIR ranks #133 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in VIR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,563,756 | 2,071,848 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $19,045,247 | 3,158,416 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $20,768,010 | 3,637,130 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $17,935,619 | 3,558,655 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,362,491 | 2,216,434 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $52,231 | 7,116 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $9,241 | 1,234 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $71,492 | 8,033 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $67,931 | 6,706 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $64,112 | 6,373 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,439,812 | 153,662 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,372,795 | 259,796 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,089,742 | 132,778 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $1,783,088 | 70,450 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $914,641 | 47,440 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $870,945 | 34,195 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $826,434 | 32,132 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $11,876,258 | 283,646 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $47 | 1 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $0 | 0 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $160 | 6 | Shares | Defined | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||